Methods and devices for providing liquids to nasal and/or paranasal cavities are disclosed. Probe portions of a first and of a second probe are introduced to a user's first and second nostril, respectively. Each probe has a primary channel and a secondary channel. Fluid is provided to the secondary channels to expand the expandable portions of the secondary channels, seal the nostril openings and expand alar sidewalls of the nostrils. This may reveal ducts that lead to the paranasal cavities. The liquid is provided through the primary channels to the nasal cavity, the liquid being disposed to reach and stimulate the soft palate, and may trigger a swallow reflex to raise the soft palate and exert pressure to the liquid, the liquid may find an escape route through the ducts and into the paranasal cavities.

A veterinary subject intranasal administration device includes a first support member portion including a septum interface portion sized for insertion into a nasal passage of the veterinary subject; an actuation mechanism connected to the first support member portion; and a fluid conduit having a distal end opposite a supported end, the distal end sized for insertion into the nasal passage of the veterinary subject, the fluid conduit being flexible and configured to receive fluid from a fluid source and discharge the fluid through the distal end into the nasal passage, the distal end of the fluid conduit being unsupported and movable relative to the septum interface portion.

The present invention provides a delivery device for intranasal administration of topical therapeutic agents to a desired site within a nasal cavity. The delivery device, in some embodiments, comprises a housing defining an interior and adapted to contain a supply of at least one therapeutic agent. The delivery device further includes a flexible connector, which is in fluid communication with the supply in the housing. A distributor, which is also integrally formed with the connector, is also provided. The distributor includes a proximal end that is in fluid communication with a distal end of the connector, and is adapted to receive the supply of the at least one therapeutic agent delivered by way of a conduit. The distributor further includes a distal end defining an outlet configured to diffuse the therapeutic agent when delivered to the treatment site.

Methods for cerebral cooling are described. Cooling assemblies include elongate tubular members, a reservoir containing a pressurized fluid, and a manifold connecting the reservoir and elongate tubular members. After insertion of the elongate tubular members into the patient's nostrils, a pressurized fluid is delivered onto a surface of the patient's nasal cavity through a plurality of ports in the elongate tubular members. The delivery of the fluid causes cooling by direct heat transfer through the nasopharynx and hematogenous cooling through the carotids and the Circle of Willis.

An intranasal device having a first cannula for insertion into a first nostril of a user and a second cannula for insertion into a second nostril of a user. Each cannula has an interior surface defining a generally cylindrical lumen. On the exterior surface of each cannula is a first protrusion in the shape of an anteromedial concavity of a nostril of the user and second, separate and distinct protrusion in the shape of a posterolateral concavity of the nostril of the user.

An automated wearable device measure physiological signals, and when parameters which cause the wearer to be at risk are measured, the device delivers an antidote for a given medical condition. This prevents overdose or medical conditions from occuring.

For the treatment of the upper respiratory system is used sea water due to its due to its anaplastic, healing and hypertonic (osmosis) characteristics, deriving if it stays for adequate time inside the nasal conchas and nose cavities. This invention for its accomplishment, guarantees a stable column of water for adequate period of time in the nasal cavities and by the ingestion (Valsava) the water is pushed in the nasal conchas and the ducts of the nose sinuses and cavities and is consisted of Central storehouses (1) having a movable pin (4) with manually-operated provides water via the pipe (5) in the mouth (8). The central pipe (5a) provides the water to the nose and the small pipe (5b) to the periphery of the mouth (8) that expands it for its sealed application and is based in two edges (10). Alternatively the pipes (5) and the mouths are joined by one (5c) which is adapted in the entrance (12) of the bag (1a) with a pin (13), moved by electricity (13) or manually-operated.

The invention pertains to the field of wearable air purifiers; specifically, filtration focused on air breathed in via the nose. A nasal air filtration apparatus comprised layered compressible inner seal, filtration material, internal malleable skeleton to allow for custom shaping, optional outer gasket, and attachment device along midline. Apparatus is flat in profile with exception of attachment device until end user modification, and has one straight side with the other side being a long arch resulting in a roughly semicircular appearance. Apparatus attaches on midline of nose to a nasal dilation device, straight side oriented towards users' upper lip, arched side along edges of nostrils. Apparatus is then molded by user to form an airtight seal around users' nose, providing filtration of inspired air.

An inhaler/puffer is provided. The inhaler/puffer may comprise a body, a cap, and a base, the cap and the base being configured to functionally engage the body. The body may define a chamber wherein minerals, such as salt, may be housed. The body, cap, and base may be configured to permit a user to inhale on the cap and draw air through the base into the chamber, over the minerals, through the cap and into the respiratory system of the user. Additionally, the inhaler/puffer may be placed in-line with an oxygen breathing system, such that as the breathing system provides oxygen to the user, the user also receives salt air treatment.

An exemplary nasal inhaler band is fitted on the upper lip below the nasal openings of a user. The device provides minimal restriction of ambient airflow into the nostrils during inhalation, while also providing a flow of beneficial vapors into such airflow. A main body of the device has an outer layer adapted to hold vapor-releasing solids, liquids or gels. The outer layer is air-permeable and absorbent. The main body also has a base layer contacting the upper lip. The base layer is impermeable, so that volatile solids, liquids or gels do not come into contact with the user's skin. The main body is held in position in contact with the nose and upper lip by elastic straps extending back from ends of the main body to wrap around the user's ears.